ABSI
Absci Corp
NASDAQ: ABSI · HEALTHCARE · BIOTECHNOLOGY
$4.71
-3.09% today
Updated 2026-04-29
Market cap
$732.16M
P/E ratio
—
P/S ratio
261.48x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $5
Volume
4.1M
Absci Corp (ABSI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $19.47M | $88.57M | $426.19M | $321.01M | $217.30M | $213.61M |
| Cash & equivalents | $13.09M | $69.87M | $252.57M | $59.95M | $72.36M | $41.21M |
| Current assets | $13.65M | $73.23M | $273.08M | $186.86M | $120.58M | $133.83M |
| Total liabilities | $60.63M | $21.56M | $60.09M | $46.59M | $41.12M | $34.48M |
| Current liabilities | $3.47M | $10.10M | $33.86M | $30.27M | $29.56M | $28.66M |
| Long-term debt | $1.75M | $4.14M | $1.12M | $7.98M | $4.66M | $1.26M |
| Shareholder equity | $-41.16M | $67.00M | $366.11M | $274.41M | $176.18M | $179.13M |
| Retained earnings | $-41.38M | $-90.06M | $-191.03M | $-295.93M | $-406.50M | $-509.60M |
| Accounts receivable | $222000.00 | $1.59M | $1.43M | $1.55M | $2.19M | $0.00 |
| Inventory | $1.00 | $1.00 | $10.51M | $15.02M | — | — |
| Goodwill | — | $0.00 | $21.34M | $21.34M | $0.00 | — |